...
首页> 外文期刊>Medicine. >Insights from the comparisons of SARS-CoV and COVID-19 outbreaks
【24h】

Insights from the comparisons of SARS-CoV and COVID-19 outbreaks

机译:SARS-COV和Covid-19爆发的比较见解

获取原文

摘要

Coronavirus disease 2019 (COVID-19) is one of infectious diseases caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At the beginning of 2020, a sudden outbreak of novel pneumonia, originated from Wuhan, China, swiftly evolves to a worldwide pandemic, alike the severe acute respiratory syndrome (SARS) in 2003. However, Chinese-style innovation in response to the outbreak of COVID-19 helped China to reach a faster and more effective success in the containment of this epidemic. This review summarizes insights from the comparisons of severe acute respiratory syndrome coronavirus (SARS-CoV) and COVID-19 outbreaks on the basis of preventive strategies in China for this coronavirus pandemic. Abbreviations: AIDS = acquired immune deficiency syndrome, COVID-19 = coronavirus disease 2019, NMPA = National Medical Products Administration, PCR = polymerase chain reaction, RT-PCR = reverse transcription polymerase chain reaction, SARS = severe acute respiratory syndrome, SARS-CoV = severe acute respiratory syndrome coronavirus, SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, WHO = World Health Organization.
机译:冠状病毒疾病2019(Covid-19)是由严重急性呼吸综合征冠状病毒2(SARS-COV-2)引起的传染病之一。在2020年初,突然爆发了中国武汉,迅速发展到全球大流行,同等于2003年的严重急性呼吸道综合征(SARS)。然而,中国式创新以应对爆发Covid-19帮助中国在遏制这种流行病方面达到了更快,更有效的成功。本综述总结了在中国对冠状病毒大流行的预防策略的基础上,总结了严重急性呼吸综合征冠状病毒(SARS-COV)和Covid-19爆发的比较的见解。缩写:艾滋病=获得的免疫缺陷综合征,Covid-19 =冠状病毒疾病2019,NMPA =国家医疗产品给药,PCR =聚合酶链反应,RT-PCR =逆转录聚合酶链反应,SARS =严重急性呼吸综合征,SARS-COV =严重急性呼吸综合征冠状病毒,SARS-COV-2 =严重急性呼吸综合征冠状病毒2,谁=世界卫生组织。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号